Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Immunome, Inc. Income Statement Banner

Immunome, Inc. Income Statement

IMNM Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.0000.0000.00014.018M
Cost of Revenue
521.000K615.000K755.000K755.000K631.000K728.000K
Gross Profit
-521.000k-615.000k-755.000k-755.000k-631.000k13.290M
Operating Expense
7.743M10.348M12.261M25.204M36.901M122.820M
Operating Income
-7.743m-10.348m-12.261m-25.204m-36.901m-109.530m
Other Income Expense
0.0000.0000.000503.000K0.00023.089M
Total Other Income Expense
-102.000k-96.000k-5.576m493.000K5.000K2.724M
Pretax Income
-7.845m-10.444m-17.837m-24.711m-36.896m-106.806m
Tax Provision
39.000K106.000K-717.000k-242.000k617.000K560.105K
Net Income
-7.845m-10.550m-17.120m-24.469m-37.513m-106.806m
Basic EPS
-1.790-1.840-5.050-2.120-3.090-5.380
Diluted EPS
-1.790-1.840-5.050-2.120-3.090-5.380
Basic Average Shares
4.390M5.744M3.390M11.539M12.127M19.844M
Diluted Average Shares
4.390M5.744M3.390M11.539M12.127M19.844M
Total Expenses
7.743M10.348M12.261M25.204M36.901M123.548M
Interest Income
39.000K10.000K1.000K10.000K5.000K2.724M
Interest Expense
141.000K106.000K38.000K10.000K5.000K0.000
EBITDA
-7.183m-9.723m-12.261m-24.701m-36.270m-108.802m
Depreciation & Amortization
521.000K615.000K755.000K755.000K631.000K728.000K